Literature DB >> 17548473

Prion protein repeat expansion results in increased aggregation and reveals phenotypic variability.

Elizabeth M H Tank1, David A Harris, Amar A Desai, Heather L True.   

Abstract

Mammalian prion diseases are fatal neurodegenerative disorders dependent on the prion protein PrP. Expansion of the oligopeptide repeats (ORE) found in PrP is associated with inherited prion diseases. Patients with ORE frequently harbor PrP aggregates, but other factors may contribute to pathology, as they often present with unexplained phenotypic variability. We created chimeric yeast-mammalian prion proteins to examine the influence of the PrP ORE on prion properties in yeast. Remarkably, all chimeric proteins maintained prion characteristics. The largest repeat expansion chimera displayed a higher propensity to maintain a self-propagating aggregated state. Strikingly, the repeat expansion conferred increased conformational flexibility, as observed by enhanced phenotypic variation. Furthermore, the repeat expansion chimera displayed an increased rate of prion conversion, but only in the presence of another aggregate, the [RNQ+] prion. We suggest that the PrP ORE increases the conformational flexibility of the prion protein, thereby enhancing the formation of multiple distinct aggregate structures and allowing more frequent prion conversion. Both of these characteristics may contribute to the phenotypic variability associated with PrP repeat expansion diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548473      PMCID: PMC1952097          DOI: 10.1128/MCB.02127-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Strains of [PSI(+)] are distinguished by their efficiencies of prion-mediated conformational conversion.

Authors:  S M Uptain; G J Sawicki; B Caughey; S Lindquist
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  The role of conformational flexibility in prion propagation and maintenance for Sup35p.

Authors:  T Scheibel; S L Lindquist
Journal:  Nat Struct Biol       Date:  2001-11

3.  Prions affect the appearance of other prions: the story of [PIN(+)].

Authors:  I L Derkatch; M E Bradley; J Y Hong; S W Liebman
Journal:  Cell       Date:  2001-07-27       Impact factor: 41.582

Review 4.  Analysis of prion factors in yeast.

Authors:  Yury O Chernoff; Susan M Uptain; Susan L Lindquist
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

5.  Yeast prion protein derivative defective in aggregate shearing and production of new 'seeds'.

Authors:  A S Borchsenius; R D Wegrzyn; G P Newnam; S G Inge-Vechtomov; Y O Chernoff
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

6.  Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion.

Authors:  L Z Osherovich; J S Weissman
Journal:  Cell       Date:  2001-07-27       Impact factor: 41.582

7.  Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions.

Authors:  S N Parham; C G Resende; M F Tuite
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

Review 8.  Similar and divergent features in mammalian and yeast prions.

Authors:  Luc Bousset; Ronald Melki
Journal:  Microbes Infect       Date:  2002-04       Impact factor: 2.700

Review 9.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

10.  [Psi(+)] prion generation in yeast: characterization of the 'strain' difference.

Authors:  N V Kochneva-Pervukhova; M B Chechenova; I A Valouev; V V Kushnirov; V N Smirnov; M D Ter-Avanesyan
Journal:  Yeast       Date:  2001-04       Impact factor: 3.239

View more
  31 in total

Review 1.  Insights into intragenic and extragenic effectors of prion propagation using chimeric prion proteins.

Authors:  Heather L True; Tejas Kalastavadi; Elizabeth M H Tank
Journal:  Prion       Date:  2008-04-17       Impact factor: 3.931

2.  Mutants of the Paf1 complex alter phenotypic expression of the yeast prion [PSI+].

Authors:  Lisa A Strawn; Changyi A Lin; Elizabeth M H Tank; Morwan M Osman; Sarah A Simpson; Heather L True
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

Review 3.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

4.  The spontaneous appearance rate of the yeast prion [PSI+] and its implications for the evolution of the evolvability properties of the [PSI+] system.

Authors:  Alex K Lancaster; J Patrick Bardill; Heather L True; Joanna Masel
Journal:  Genetics       Date:  2009-11-16       Impact factor: 4.562

Review 5.  Prions in yeast.

Authors:  Susan W Liebman; Yury O Chernoff
Journal:  Genetics       Date:  2012-08       Impact factor: 4.562

Review 6.  Probing the role of structural features of mouse PrP in yeast by expression as Sup35-PrP fusions.

Authors:  Lyne Jossé; Ricardo Marchante; Jo Zenthon; Tobias von der Haar; Mick F Tuite
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

7.  De novo design of synthetic prion domains.

Authors:  James A Toombs; Michelina Petri; Kacy R Paul; Grace Y Kan; Asa Ben-Hur; Eric D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 8.  The [RNQ+] prion: a model of both functional and pathological amyloid.

Authors:  Kevin C Stein; Heather L True
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

9.  Compositional determinants of prion formation in yeast.

Authors:  James A Toombs; Blake R McCarty; Eric D Ross
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

10.  Screening for amyloid aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis.

Authors:  Randal Halfmann; Susan Lindquist
Journal:  J Vis Exp       Date:  2008-07-16       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.